AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

In its annual 'Measuring the Return from Pharmaceutical Innovation' report based on the top 20 pharma companies by 2020 R&D ...

Merck & Co. (MRK) releases positive phase three data for its injectable-form cancer drug Keytruda. Yahoo Finance Senior ...

The state’s second-largest insurer is grappling with heightened health care spending and a market that is increasingly unable ...

Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved 24% weight reduction at 48 weeks in a ...

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

More than $4 billion was spent on drug advertising in 2023, led by blockbuster drugs like weight-loss treatment Wegovy, The ...